Landos Biopharma, Inc. Quarterly Common Stock, Shares, Issued from Q4 2020 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Landos Biopharma, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2020 to Q1 2024.
  • Landos Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending March 31, 2024 was 3.12M shares, a 90% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 3.12M -28.1M -90% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 3.12M -909K -22.6% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 3.12M -37.1M -92.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 3.12M -37.1M -92.3% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 31.2M -9.09M -22.6% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 4.03M -36.2M -90% Dec 31, 2022 10-K 2024-03-21
Q3 2022 40.3M +202K +0.5% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 40.3M +354K +0.89% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 40.3M +388K +0.97% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 40.3M 0 0% Dec 31, 2021 10-K 2023-03-23
Q3 2021 40.1M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 39.9M Jun 30, 2021 10-Q 2021-07-29
Q1 2021 39.9M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 40.3M Dec 31, 2020 10-K 2022-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.